Neuropsychiatric disorders that frequently initially emerge during adolescence are associated with deficits in the omega-3 (n-3) fatty acid docosahexaenoic acid (DHA), elevated proinflammatory signaling, and regional reductions in white matter integrity (WMI). This study determined the effects of altering brain DHA accrual during adolescence on WMI in the rat brain by diffusion tensor imaging (DTI), and investigated the potential mediating role of proinflammatory signaling. During periadolescent development, male rats were fed a diet deficient in n-3 fatty acids (DEF, n = 20), a fish oil-fortified diet containing preformed DHA (FO, n = 20), or a control diet (CON, n = 20). In adulthood, DTI scans were performed and brain WMI was determined using voxelwise tract-based spatial statistics (TBSS). Postmortem fatty acid composition, peripheral (plasma IL-1β, IL-6, and C-reactive protein [CRP]) and central (IL-1β and CD11b mRNA) proinflammatory markers, and myelin basic protein (MBP) mRNA expression were determined. Compared with CON rats, forebrain DHA levels were lower in DEF rats and higher in FO rats. Compared with CON rats, DEF rats exhibited greater radial diffusivity (RD) and mean diffusivity in the right external capsule, and greater axial diffusivity in the corpus callosum genu and left external capsule. DEF rats also exhibited greater RD than FO rats in the right external capsule. Forebrain MBP expression did not differ between groups. Compared with CON rats, central (IL-1β and CD11b) and peripheral (IL-1β and IL-6) proinflammatory markers were not different in DEF rats, and DEF rats exhibited lower CRP levels. These findings demonstrate that deficits in adolescent DHA accrual negatively impact forebrain WMI, independently of elevated proinflammatory signaling.

Keywords:
Omega-3 fatty acids, Docosahexaenoic acid, Inflammation, Myelin, Diffusion tensor imaging, Rat
1.
Aston C, Jiang L, Sokolov BP: Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005;10:309-322.
2.
Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, et al: Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003;362:798-805.
3.
Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC: Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 2007;151:179-188.
4.
Yao L, Lui S, Liao Y, Du MY, Hu N, Thomas JA, et al: White matter deficits in first episode schizophrenia: an activation likelihood estimation meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2013;45:100-106.
5.
Nortje G, Stein DJ, Radua J, Mataix-Cols D, Horn N: Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. J Affect Disord 2013;150:192-200.
6.
Jiang J, Zhao YJ, Hu XY, Du MY, Chen ZQ, Wu M, et al: Microstructural brain abnormalities in medication-free patients with major depressive disorder: a systematic review and meta-analysis of diffusion tensor imaging. J Psychiatry Neurosci 2017;42:150-163.
7.
Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B: Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996;7:354-370.
8.
Popko B, Baerwald KD: Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res 1999;24:331-338.
9.
Stolp HB, Dziegielewska KM, Ek CJ, Potter AM, Saunders NR: Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur J Neurosci 2005;22:2805-2816.
10.
Stolp HB, Ek CJ, Johansson PA, Dziegielewska KM, Bethge N, Wheaton BJ, et al: Factors involved in inflammation-induced developmental white matter damage. Neurosci Lett 2009;451:232-236.
11.
Upthegrove R, Manzanares-Teson N, Barnes NM: Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 2014;155:101-108.
12.
Modabbernia A, Taslimi S, Brietzke E, Ashrafi M: Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 2013;74:15-25.
13.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al: A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-457.
14.
Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambrée O, de Wit H, et al: Inflammatory cytokines influence measures of white matter integrity in bipolar disorder. J Affect Disord 2016;202:1-9.
15.
Prasad KM, Upton CH, Nimgaonkar VL, Keshavan MS: Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study. Schizophr Res 2015;161:119-125.
16.
Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST: Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 2003;100:1751-1756.
17.
Groeger AL, Cipollina C, Cole MP, Woodcock SR, Bonacci G, Rudolph TK, et al: Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol 2010;6:433-441.
18.
Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y: Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 1997;400:589-597.
19.
Lotrich FE, Sears B, McNamara RK: Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6. Brain Behav Immun 2013;31:48-53.
20.
McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton JW: Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 2010;83:185-191.
21.
Orr SK, Palumbo S, Bosetti F, Mount HT, Kang JX, Greenwood CE, et al: Unesterified docosahexaenoic acid is protective in neuroinflammation. J Neurochem 2013;127:378-393.
22.
McNamara RK, Szeszko PR, Smesny S, Ikuta T, DeRosse P, Vaz FM, et al: Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence. Neuroscience 2017;343:423-433.
23.
Peters BD, Voineskos AN, Szeszko PR, Lett TA, DeRosse P, Guha S, et al: Brain white matter development is associated with a human-specific haplotype increasing the synthesis of long chain fatty acids. J Neurosci 2014;34:6367-6376.
24.
Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, et al: Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014;24:3059-3068.
25.
Chhetry BT, Hezghia A, Miller JM, Lee S, Rubin-Falcone H, Cooper TB, et al: Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression. J Psychiatr Res 2016;75:65-74.
26.
Peters BD, Machielsen MW, Hoen WP, Caan MW, Malhotra AK, Szeszko PR, et al: Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis. Schizophr Bull 2013;39:830-838.
27.
van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE: A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophr Res 2012;141:153-161.
28.
McNamara RK, Welge JA: Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. Bipolar Disord 2016;18:300-306.
29.
Lin PY, Huang SY, Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010;68:140-147.
30.
Bernardo A, Giammarco ML, De Nuccio C, Ajmone-Cat MA, Visentin S, De Simone R, et al: Docosahexaenoic acid promotes oligodendrocyte differentiation via PPAR-γ signalling and prevents tumor necrosis factor-α-dependent maturational arrest. Biochim Biophys Acta 2017;1862:1013-1023.
31.
Salvati S, Natali F, Attorri L, Di Benedetto R, Leonardi F, Di Biase A, et al: Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain. J Neurosci Res 2008;86:776-784.
32.
Ward RE, Huang W, Curran OE, Priestley JV, Michael-Titus AT: Docosahexaenoic acid prevents white matter damage after spinal cord injury. J Neurotrauma 2010;27:1769-1780.
33.
Tuzun F, Kumral A, Dilek M, Ozbal S, Ergur B, Yesilirmak DC, et al: Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain. J Matern Fetal Neonatal Med 2012;25:849-854.
34.
Kong W, Yen JH, Ganea D: Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav Immun 2011;25:872-882.
35.
Church MW, Jen KL, Dowhan LM, Adams BR, Hotra JW: Excess and deficient omega-3 fatty acid during pregnancy and lactation cause impaired neural transmission in rat pups. Neurotoxicol Teratol 2008;30:107-117.
36.
Church MW, Jen KL, Jackson DA, Adams BR, Hotra JW: Abnormal neurological responses in young adult offspring caused by excess omega-3 fatty acid (fish oil) consumption by the mother during pregnancy and lactation. Neurotoxicol Teratol 2009;31:26-33.
37.
Haubner L, Sullivan J, Ashmeade T, Saste M, Wiener D, Carver J: The effects of maternal dietary docosahexaenoic acid intake on rat pup myelin and the auditory startle response. Dev Neurosci 2007;29:460-467.
38.
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al: Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-1505.
39.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al: Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23:208-219.
40.
Smith SM: Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143-155.
41.
Schweinhardt P, Fransson P, Olson L, Spenger C, Andersson JL: A template for spatial normalisation of MR images of the rat brain. J Neurosci Methods 2003;129:105-113.
42.
Andersson JLR, Jenkinson M, Smith S: Non-linear optimisation. FMRIB Technical Report TR07JA1. www.fmrib.ox.ac.uk/analysis/techrep.
43.
Andersson JLR, Jenkinson M, Smith S: Non-linear registration, aka spatial normalization. FMRIB Technical Report TR07JA2. www. fmrib.ox.ac.uk/analysis/techrep.
44.
Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hawkes DJ: Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 1999;18:712-721.
45.
McNamara RK, Able JA, Jandacek RJ, Rider T, Tso P: Inbred C57BL/6J and DBA/2J mouse strains exhibit constitutive differences in regional brain fatty acid composition. Lipids 2009;44:1-8.
46.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001;25:402-408.
47.
Budde MD, Xie M, Cross AH, Song SK: Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci 2009;29:2805-2813.
48.
Janve VA, Zu Z, Yao SY, Li K, Zhang FL, Wilson KJ, et al: The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions. Neuroimage 2013;74:298-305.
49.
Nair G, Tanahashi Y, Low HP, Billings-Gagliardi S, Schwartz WJ, Duong TQ: Myelination and long diffusion times alter diffusion-tensor-imaging contrast in myelin-deficient shiverer mice. Neuroimage 2005;28:165-174.
50.
Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH: Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429-1436.
51.
Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH: Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003;20:1714-1722.
52.
Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, et al: Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26:132-140.
53.
Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK: Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 2006;55:302-308.
54.
Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, et al: Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 2006;21:626-632.
55.
Klawiter EC, Schmidt RE, Trinkaus K, Liang HF, Budde MD, Naismith RT, et al: Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage 2011;55:1454-1460.
56.
Schober ME, Requena DF, Abdullah OM, Casper TC, Beachy J, Malleske D, et al: Dietary docosahexaenoic acid improves cognitive function, tissue sparing, and magnetic resonance imaging indices of edema and white matter injury in the immature rat after traumatic brain injury. J Neurotrauma 2016;33:390-402.
57.
Chang EH, Argyelan M, Aggarwal M, Chandon TS, Karlsgodt KH, Mori S, et al: Diffusion tensor imaging measures of white matter compared to myelin basic protein immunofluorescence in tissue cleared intact brains. Data Brief 2016;10:438-443.
58.
Vancassel S, Aïd S, Pifferi F, Morice E, Nosten-Bertrand M, Chalon S, Lavialle M: Cerebral asymmetry and behavioral lateralization in rats chronically lacking n-3 polyunsaturated fatty acids. Biol Psychiatry 2005;58:805-811.
59.
Bockhorst KH, Narayana PA, Liu R, Ahobila-Vijjula P, Ramu J, Kamel M, et al: Early postnatal development of rat brain: in vivo diffusion tensor imaging. J Neurosci Res 2008;86:1520-1528.
60.
Yavin E, Himovichi E, Eilam R: Delayed cell migration in the developing rat brain following maternal omega 3 alpha linolenic acid dietary deficiency. Neuroscience 2009;162:1011-1022.
61.
Szeszko PR, Robinson DG, Ikuta T, Peters BD, Gallego JA, Kane J, et al: White matter changes associated with antipsychotic treatment in first-episode psychosis. Neuropsychopharmacology 2014;39:1324-1331.
62.
LeWinn KZ, Connolly CG, Wu J, Drahos M, Hoeft F, Ho TC, et al: White matter correlates of adolescent depression: structural evidence for frontolimbic disconnectivity. J Am Acad Child Adolesc Psychiatry 2014;53:899-909.
63.
Zeng B, Ardekani BA, Tang Y, Zhang T, Zhao S, Cui H, et al: Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment. Schizophr Res 2016;172:1-8.
64.
Lu LH, Zhou XJ, Fitzgerald J, Keedy SK, Reilly JL, Passarotti AM, et al: Microstructural abnormalities of white matter differentiate pediatric and adult-onset bipolar disorder. Bipolar Disord 2012;14:597-606.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.